APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lurasidone

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lurasidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174009450331 December 2025187 pages

Choose your research edition.

Industry ResearchLurasidone Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Lurasidone Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Lurasidone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lurasidone Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Lurasidone Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lurasidone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lurasidone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lurasidone include Zhejiang Hisun Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Square Pharmaceuticals Ltd., RemedyRepack，Inc., Incepta Pharmaceuticals Ltd., Healthcare Pharmaceuticals Limited, Bushu Pharmaceutical, LTD. and Angelini Holding S.p.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lurasidone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lurasidone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lurasidone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lurasidone market size, projected growth trends, production technologies, key applications, and end-use industries.

Lurasidone Segment by Company

Zhejiang Hisun Pharmaceutical Co., Ltd.

Sumitomo Dainippon Pharma Co., Ltd.

Square Pharmaceuticals Ltd.

RemedyRepack，Inc.

Incepta Pharmaceuticals Ltd.

Healthcare Pharmaceuticals Limited

Bushu Pharmaceutical, LTD.

Angelini Holding S.p.A.

Lurasidone Segment by Type

120mg/tablet

20mg/tablet

40mg/tablet

60mg/tablet

80mg/tablet

Lurasidone Segment by Application

Hospital

Psychological Clinic

Others

Lurasidone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lurasidone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lurasidone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lurasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lurasidone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lurasidone Industry Trends Table 2. Lurasidone Industry Drivers Table 3. Lurasidone Industry Opportunities and Challenges Table 4. Lurasidone Industry Restraints Table 5. Global Lurasidone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lurasidone Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lurasidone Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lurasidone Sales Market Share by Manufacturers Table 9. Global Lurasidone Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lurasidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lurasidone Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lurasidone Manufacturers, Product Type & Application Table 13. Global Lurasidone Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lurasidone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 120mg/tablet Table 17. Major Manufacturers of 20mg/tablet Table 18. Major Manufacturers of 40mg/tablet Table 19. Major Manufacturers of 60mg/tablet Table 20. Major Manufacturers of 80mg/tablet Table 21. Global Lurasidone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Lurasidone Sales by Type (2021-2026) & (K Units) Table 23. Global Lurasidone Sales by Type (2027-2032) & (K Units) Table 24. Global Lurasidone Sales Market Share by Type (2021-2026) Table 25. Global Lurasidone Sales Market Share by Type (2027-2032) Table 26. Global Lurasidone Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Lurasidone Revenue by Type (2021-2026) & (K Units) Table 28. Global Lurasidone Revenue by Type (2027-2032) & (K Units) Table 29. Global Lurasidone Revenue Market Share by Type (2021-2026) Table 30. Global Lurasidone Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Hospital Table 32. Major Manufacturers of Psychological Clinic Table 33. Major Manufacturers of Others Table 34. Global Lurasidone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Lurasidone Sales by Application (2021-2026) & (K Units) Table 36. Global Lurasidone Sales by Application (2027-2032) & (K Units) Table 37. Global Lurasidone Sales Market Share by Application (2021-2026) Table 38. Global Lurasidone Sales Market Share by Application (2027-2032) Table 39. Global Lurasidone Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Lurasidone Revenue by Application (2021-2026) & (K Units) Table 41. Global Lurasidone Revenue by Application (2027-2032) & (K Units) Table 42. Global Lurasidone Revenue Market Share by Application (2021-2026) Table 43. Global Lurasidone Revenue Market Share by Application (2027-2032) Table 44. Global Lurasidone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Lurasidone Sales by Region (2021-2026) & (K Units) Table 46. Global Lurasidone Sales Market Share by Region (2021-2026) Table 47. Global Lurasidone Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Lurasidone Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Lurasidone Sales by Country (2021-2026) & (K Units) Table 51. North America Lurasidone Sales by Country (2027-2032) & (K Units) Table 52. Europe Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Lurasidone Sales by Country (2021-2026) & (K Units) Table 54. Europe Lurasidone Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Lurasidone Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Lurasidone Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Lurasidone Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Lurasidone Sales by Country (2027-2032) & (K Units) Table 61. Global Lurasidone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Lurasidone Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Lurasidone Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Lurasidone Revenue Market Share by Region (2021-2026) Table 65. Global Lurasidone Revenue Market Share by Region (2027-2032) Table 66. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information Table 67. Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview Table 68. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio Table 70. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Development Table 71. Sumitomo Dainippon Pharma Co., Ltd. Company Information Table 72. Sumitomo Dainippon Pharma Co., Ltd. Business Overview Table 73. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio Table 75. Sumitomo Dainippon Pharma Co., Ltd. Recent Development Table 76. Square Pharmaceuticals Ltd. Company Information Table 77. Square Pharmaceuticals Ltd. Business Overview Table 78. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Square Pharmaceuticals Ltd. Lurasidone Product Portfolio Table 80. Square Pharmaceuticals Ltd. Recent Development Table 81. RemedyRepack，Inc. Company Information Table 82. RemedyRepack，Inc. Business Overview Table 83. RemedyRepack，Inc. Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. RemedyRepack，Inc. Lurasidone Product Portfolio Table 85. RemedyRepack，Inc. Recent Development Table 86. Incepta Pharmaceuticals Ltd. Company Information Table 87. Incepta Pharmaceuticals Ltd. Business Overview Table 88. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio Table 90. Incepta Pharmaceuticals Ltd. Recent Development Table 91. Healthcare Pharmaceuticals Limited Company Information Table 92. Healthcare Pharmaceuticals Limited Business Overview Table 93. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio Table 95. Healthcare Pharmaceuticals Limited Recent Development Table 96. Bushu Pharmaceutical, LTD. Company Information Table 97. Bushu Pharmaceutical, LTD. Business Overview Table 98. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio Table 100. Bushu Pharmaceutical, LTD. Recent Development Table 101. Angelini Holding S.p.A. Company Information Table 102. Angelini Holding S.p.A. Business Overview Table 103. Angelini Holding S.p.A. Lurasidone Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Angelini Holding S.p.A. Lurasidone Product Portfolio Table 105. Angelini Holding S.p.A. Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Lurasidone Distributors List Table 109. Lurasidone Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Lurasidone Product Image Figure 2. Global Lurasidone Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lurasidone Market Size (2021-2032) & (US$ Million) Figure 4. Global Lurasidone Sales (2021-2032) & (K Units) Figure 5. Global Lurasidone Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lurasidone Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 120mg/tablet Image Figure 9. 20mg/tablet Image Figure 10. 40mg/tablet Image Figure 11. 60mg/tablet Image Figure 12. 80mg/tablet Image Figure 13. Global Lurasidone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Lurasidone Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Lurasidone Sales Market Share by Type (2021-2032) Figure 16. Global Lurasidone Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Lurasidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Lurasidone Revenue Market Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Psychological Clinic Image Figure 21. Others Image Figure 22. Global Lurasidone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Lurasidone Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Lurasidone Sales Market Share by Application (2021-2032) Figure 25. Global Lurasidone Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Lurasidone Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Lurasidone Revenue Market Share by Application (2021-2032) Figure 28. North America Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Lurasidone Sales Market Share by Country (2021-2032) Figure 30. U.S. Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Lurasidone Sales Market Share by Country (2021-2032) Figure 35. Germany Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Lurasidone Sales Market Share by Country (2021-2032) Figure 42. China Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Lurasidone Sales Market Share by Country (2021-2032) Figure 50. Brazil Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Lurasidone Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Lurasidone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Lurasidone Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Lurasidone Revenue (2021-2032) & (US$ Million) Figure 61. North America Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Lurasidone Revenue (2021-2032) & (US$ Million) Figure 63. Europe Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Lurasidone Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Lurasidone Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Lurasidone Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Lurasidone Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 120mg/tablet
  • 20mg/tablet
  • 40mg/tablet
  • 60mg/tablet
  • 80mg/tablet
Applications
  • Hospital
  • Psychological Clinic
  • Others
Companies covered
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Square Pharmaceuticals Ltd.
  • RemedyRepack，Inc.
  • Incepta Pharmaceuticals Ltd.
  • Healthcare Pharmaceuticals Limited
  • Bushu Pharmaceutical, LTD.
  • Angelini Holding S.p.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lurasidone Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lurasidone Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lurasidone Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lurasidone Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lurasidone Market Dynamics
  1. 2.1 Lurasidone Industry Trends
  2. 2.2 Lurasidone Industry Drivers
  3. 2.3 Lurasidone Industry Opportunities and Challenges
  4. 2.4 Lurasidone Industry Restraints
3 Lurasidone Market by Manufacturers
  1. 3.1 Global Lurasidone Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lurasidone Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lurasidone Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lurasidone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lurasidone Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lurasidone Manufacturers, Product Type & Application
  7. 3.7 Global Lurasidone Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lurasidone Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lurasidone Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lurasidone Tier 1, Tier 2, and Tier 3
4 Lurasidone Market by Type
  1. 4.1 Lurasidone Type Introduction
  2. 4.1.1 120mg/tablet
  3. 4.1.2 20mg/tablet
  4. 4.1.3 40mg/tablet
  5. 4.1.4 60mg/tablet
  6. 4.1.5 80mg/tablet
  7. 4.2 Global Lurasidone Sales by Type
  8. 4.2.1 Global Lurasidone Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Lurasidone Sales by Type (2021-2032)
  10. 4.2.3 Global Lurasidone Sales Market Share by Type (2021-2032)
  11. 4.3 Global Lurasidone Revenue by Type
  12. 4.3.1 Global Lurasidone Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Lurasidone Revenue by Type (2021-2032)
  14. 4.3.3 Global Lurasidone Revenue Market Share by Type (2021-2032)
5 Lurasidone Market by Application
  1. 5.1 Lurasidone Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Psychological Clinic
  4. 5.1.3 Others
  5. 5.2 Global Lurasidone Sales by Application
  6. 5.2.1 Global Lurasidone Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lurasidone Sales by Application (2021-2032)
  8. 5.2.3 Global Lurasidone Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lurasidone Revenue by Application
  10. 5.3.1 Global Lurasidone Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lurasidone Revenue by Application (2021-2032)
  12. 5.3.3 Global Lurasidone Revenue Market Share by Application (2021-2032)
6 Global Lurasidone Sales by Region
  1. 6.1 Global Lurasidone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lurasidone Sales by Region (2021-2032)
  3. 6.2.1 Global Lurasidone Sales by Region (2021-2026)
  4. 6.2.2 Global Lurasidone Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lurasidone Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lurasidone Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lurasidone Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lurasidone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lurasidone Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lurasidone Revenue by Region
  1. 7.1 Global Lurasidone Revenue by Region
  2. 7.1.1 Global Lurasidone Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lurasidone Revenue by Region (2021-2026)
  4. 7.1.3 Global Lurasidone Revenue by Region (2027-2032)
  5. 7.1.4 Global Lurasidone Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lurasidone Revenue (2021-2032)
  8. 7.2.2 North America Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lurasidone Revenue (2021-2032)
  11. 7.3.2 Europe Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lurasidone Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lurasidone Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lurasidone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Hisun Pharmaceutical Co., Ltd.
  2. 8.1.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Portfolio
  6. 8.1.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Sumitomo Dainippon Pharma Co., Ltd.
  8. 8.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
  9. 8.2.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
  10. 8.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Portfolio
  12. 8.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
  13. 8.3 Square Pharmaceuticals Ltd.
  14. 8.3.1 Square Pharmaceuticals Ltd. Company Information
  15. 8.3.2 Square Pharmaceuticals Ltd. Business Overview
  16. 8.3.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Square Pharmaceuticals Ltd. Lurasidone Product Portfolio
  18. 8.3.5 Square Pharmaceuticals Ltd. Recent Developments
  19. 8.4 RemedyRepack，Inc.
  20. 8.4.1 RemedyRepack，Inc. Company Information
  21. 8.4.2 RemedyRepack，Inc. Business Overview
  22. 8.4.3 RemedyRepack，Inc. Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 RemedyRepack，Inc. Lurasidone Product Portfolio
  24. 8.4.5 RemedyRepack，Inc. Recent Developments
  25. 8.5 Incepta Pharmaceuticals Ltd.
  26. 8.5.1 Incepta Pharmaceuticals Ltd. Company Information
  27. 8.5.2 Incepta Pharmaceuticals Ltd. Business Overview
  28. 8.5.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Portfolio
  30. 8.5.5 Incepta Pharmaceuticals Ltd. Recent Developments
  31. 8.6 Healthcare Pharmaceuticals Limited
  32. 8.6.1 Healthcare Pharmaceuticals Limited Company Information
  33. 8.6.2 Healthcare Pharmaceuticals Limited Business Overview
  34. 8.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Portfolio
  36. 8.6.5 Healthcare Pharmaceuticals Limited Recent Developments
  37. 8.7 Bushu Pharmaceutical, LTD.
  38. 8.7.1 Bushu Pharmaceutical, LTD. Company Information
  39. 8.7.2 Bushu Pharmaceutical, LTD. Business Overview
  40. 8.7.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bushu Pharmaceutical, LTD. Lurasidone Product Portfolio
  42. 8.7.5 Bushu Pharmaceutical, LTD. Recent Developments
  43. 8.8 Angelini Holding S.p.A.
  44. 8.8.1 Angelini Holding S.p.A. Company Information
  45. 8.8.2 Angelini Holding S.p.A. Business Overview
  46. 8.8.3 Angelini Holding S.p.A. Lurasidone Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Angelini Holding S.p.A. Lurasidone Product Portfolio
  48. 8.8.5 Angelini Holding S.p.A. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lurasidone Value Chain Analysis
  2. 9.1.1 Lurasidone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lurasidone Production Mode & Process
  6. 9.2 Lurasidone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lurasidone Distributors
  9. 9.2.3 Lurasidone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst